U.S. District Court Granted Ortho-McNeil Neurologics, Inc.’s Request for Preliminary Injunction for TOPAMAX®
The request of Ortho-McNeil Neurologics, Inc. (a subsidiary of Johnson & Johnson, NYSE: JNJ) for a preliminary injunction against Mylan Laboratories, Inc. (NYSE: MYL) has been granted by a U.S. District court, thereby prohibiting Mylan from launching a generic version of topiramate (TOPAMAX®) prior to a final court decision on the validity of the patent.
Until the district court has rendered a final decision regarding the validity of the TOPAMAX® patent (expiring in September 2008), the abovementioned preliminary injunction will be in effect.
Source: PR Newswire
The said injunction has been granted by Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey in Newark, N.J. on October 23, 2006.
Comment Preview